| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |